Research and clinical trials

If confirmed, distinct circulating T- and B-cell patterns could help researchers and clinicians better understand immune differences in patients who have both ankylosing spondylitis and Crohn's disease, and could point...

Based on the title and source metadata, this appears to be a clinical study related to Ulcerative colitis, Inflammatory bowel disease, and Anti-TNF. The original article is from iScience.

The paper identifies a molecular pathway (SERPINB5–MMP9–RLN2) by which the HDAC inhibitor trichostatin A reduced inflammation and protected the intestinal barrier in mouse and cell models of ulcerative colitis,...

Extraintestinal manifestations (skin, joint, eye, liver) are common in IBD and can greatly affect quality of life; better recognition and coordinated care can speed diagnosis and improve outcomes.

The paper identifies a molecular pathway (miR-31-5p/SATB2) linked to UC progression to colitis-associated cancer and reports that resveratrol modulates this axis in mice, suggesting a potential preventive mechanism worth...

GPX and selenium-related pathways may be important to how oxidative stress, ferroptosis, and the microbiome contribute to IBD. Understanding these mechanisms could guide future therapies.

If confirmed, a pathology marker visible on routine biopsy (EGC patterns by SOX10 IHC) could help predict which children with ulcerative colitis are more likely to have improved mucosal inflammation over the first year,...

Based on the title and source metadata, this appears to be a regulatory update related to Ulcerative colitis, Inflammatory bowel disease, and Research and clinical trials. The original article is from Immunopharmacology...

If EPS helps restrain inflammation by shifting macrophages toward an M2 phenotype and is reduced in active UC, it could help explain mechanisms of mucosal inflammation and point to new biomarker or therapeutic strategies...

A model that predicts one-year risks for surgery and complications by Montreal phenotype could help identify patients at higher short-term risk and guide research into targeted monitoring or interventions.

The paper suggests that the same herbal formula can produce different absorbed components and target interactions depending on oral versus colonic delivery, which could influence therapeutic effects in ulcerative colitis...

Disease-related changes in liver drug-metabolizing enzymes may alter how herbal formulas or medications are processed in people with UC, potentially affecting efficacy or safety. Understanding the mechanisms helps inform...

The study identifies HK2 inhibition as a potential mechanism to shift pro-inflammatory macrophages and reduce intestinal inflammation in preclinical models, which could guide future drug development for IBD.

People with IBD may hear about botanical treatments; this study provides preclinical data that Micromeria imbricata extracts showed beneficial effects in a mouse colitis model and identified compounds that dock to...

A simple blood-derived neutrophil activation marker (Neut-RI) correlated with clinical disease activity in ulcerative colitis and outperformed fecal calprotectin and CRP in this study, suggesting a potential low-cost,...

Fungi in the gut appear to influence immune pathways implicated in IBD and other autoimmune diseases, suggesting new therapeutic targets and microbiome-based interventions that could affect disease activity.

This paper outlines research strategies aiming to deliver drugs more precisely to inflamed gut tissue and to reshape immune-cell behavior — advances that could eventually lead to safer, more targeted IBD treatments. It’s...

Macrophages are central regulators of intestinal inflammation and repair; understanding their diversity and how to modulate them could lead to new, more targeted treatments for Crohn's disease and ulcerative colitis.

Short periods of extreme heat may modestly increase the chance of hospitalization for IBD and Crohn’s disease. Patients and clinicians should be aware that temperature extremes could be a trigger for worsening disease...

Researchers found a candidate shared microbial signal across colorectal cancer, Crohn’s disease, and liver cirrhosis that points to redox-related microbial functions; this could guide future biomarker or experimental...

If validated, impaired oxalate handling could help explain why some people with IBD react differently to the same plant-rich diet and point to new dietary or microbiome-based interventions to reduce gut inflammation.

The study tests a molecular technique (ATR-FTIR) with machine learning on biopsy tissue to find signals linked to future dysplasia/CRC risk in IBD — a potential complement to colonoscopic surveillance if validated.

Researchers and clinicians are watching new oral therapies for patients whose disease has failed biologic treatments. If supported by full data, a safe, oral drug that helps refractory Crohn’s disease and ulcerative...

This hire signals Coultreon is prioritizing commercial and development work on its SIK3 inhibitor COL-5671, which the company highlights as a potential oral treatment relevant to ulcerative colitis and Crohn’s disease.

Shows molecular correlates (reduced IL‑17 signaling and IL‑1β) linked with mucosal healing after exclusive enteral nutrition in children with Crohn's disease, which may help researchers develop biomarkers or understand...

Pediatric-onset IBD can behave differently than adult-onset disease. Comparing conventional versus biologic approaches in children may help clarify relative effectiveness, safety, and impacts on growth and steroid...

Fatigue is a common, disabling symptom in people with quiescent IBD and currently lacks approved pharmacological treatments. This trial tests whether modafinil can safely reduce fatigue and improve daily functioning for...

Psychological distress and gut–brain interactions can worsen quality of life and IBD outcomes. A culturally tailored, scalable digital mind–body program could improve access to psychosocial care for Black and Hispanic...

Based on the title and source metadata, this appears to be a basic science related to Ulcerative colitis, Inflammatory bowel disease, and Microbiome. The original article is from Materials today. Bio.

Endoscopic scores guide detection and treatment of postoperative Crohn's recurrence; better scoring could change who gets earlier therapy and potentially prevent clinical or surgical relapse.

Pathology reports often list microscopic findings that reflect disease activity. Knowing which histologic features are frequently seen in relapsing ulcerative colitis helps patients and clinicians interpret biopsy...

PUC often behaves differently and more aggressively than adult-onset UC; understanding pediatric‑specific causes and treatments could lead to better, more effective therapies for children.

A pooled analysis of cardiovascular risk tied to advanced IBD therapies could affect treatment decisions and monitoring plans because some immune-targeted drugs have been linked to cardiovascular safety concerns in other...

Accurate methods and dataset labels matter for researchers reproducing transcriptomic analyses and for clinicians interpreting translational implications. The corrigendum clarifies which datasets and experimental models...

The paper identifies macrophage SELENOP as a regulator of oxidative stress and neutrophil behavior in Crohn’s disease samples and mouse models, pointing to a new mechanism that could become a target for future treatments...

Defining whether IBD therapies prevent long-term damage matters to patients and clinicians because it affects treatment goals and long-term care planning.

Better imaging of intestinal cells could help researchers find previously unseen changes in the gut barrier that contribute to IBD, which might eventually guide more targeted therapies or diagnostics.

A test that identifies trigger foods from the esophagus could reduce the need for repeated endoscopies and make dietary treatment for EoE more accurate, affordable, and patient-friendly.

The work explores fundamental mechanisms by which inflammation may impair colonic epithelial identity and barrier integrity in ulcerative colitis — knowledge that could lead to new targets to improve mucosal healing.

This funded project aims to map how specific gut microbes shape metabolic outputs (like bile acids and hydrogen consumption) that may contribute to IBS symptoms and IBD-related metabolic lesions.

This project investigates how estrogen receptor signaling in intestinal epithelial cells drives sex-specific responses to injury and inflammation that may influence ulcerative colitis risk and progression.

Patients and clinicians struggle to predict relapse in ulcerative colitis because current endoscopic, histologic, and noninvasive biomarkers are imperfect. A tissue-based imaging and spatial-omics approach could identify...

Based on the title and source metadata, this appears to be a systematic review or meta analysis related to Inflammatory bowel disease and Research and clinical trials. The original article is from Journal of clinical...

The study links a common dietary compound (oxalate) to worsened intestinal inflammation in IBD and identifies reduced gut oxalate-transport gene activity and microbiome differences as possible mechanisms—findings that...

Better detection of enteric infections during suspected IBD flares could help avoid unnecessary escalation of immunosuppressive therapy and guide appropriate antibiotic use. This review suggests MPCR finds more pathogens...

If true, using infliximab drug-level modeling plus routine blood tests could help predict who has mucosal healing without immediate endoscopy, potentially reducing invasive procedures and improving monitoring for people...

The study shows that fecal (luminal) and mucosal microbiome and metabolite profiles capture different aspects of pediatric IBD—activity versus phenotype—so combined sampling may give a fuller picture for research and...

A blood biomarker that reliably indicates mucosal healing could reduce reliance on colonoscopy, help monitor disease activity more frequently, and better guide treatment decisions in UC.